A61L26/0038

NANOFIBER AND MICROFIBER HYBRID AEROGELS
20240374786 · 2024-11-14 ·

Hybrid aerogels comprising nanofibers and microfibers are provided as well as methods of use thereof and methods of making.

IONIC LIQUIDS THAT STERILIZE AND PREVENT BIOFILM FORMATION IN SKIN WOUND HEALING DEVICES

Compositions for enhancing wound healing are disclosed herein. Also disclosed are methods of making the compositions and methods of using the compositions for the prevention of biofilm formation and for the inhibition of pathogen growth and proliferation.

COMPOSITION, ARTICLES AND METHODS FOR WOUND CARE

Delivery articles for wound and surgical site treatment to prevent adhesion, provide antimicrobial benefits, and provide tissue scaffolding or support. The articles include (1) a dispensing unit or similar apparatus, the dispensing unit being selected from a pressurized or pressurizable apparatus. The dispensing unit contains (2) (a) a PGS resin, optionally including micronized PGS thermoset resin (b) a solvent (c) optionally, a propellant or other dispersant, (d) optionally, a mixture or suspension or dispersion or solution of one or more biologic tissue engineering ECM-compatible biologic components, antimicrobials, drugs, growth enhancers, stimulants, trophic agents, tissues, tissue matrices, and cells, and (e) optionally, one or a combination of structural matrix materials, fibers and fillers, gelatin and collagen.

Bioadhesive and injectable hydrogel

The present invention provides a novel hydrogel, methods of its use, and methods for producing the hydrogel.

COMPOSITIONS AND METHODS FOR MACROPHAGE CONVERSION
20240399022 · 2024-12-05 ·

One aspect of the invention provides a method of treating a chronic wound including administering to the wound at least one agent from a delivery system wherein the agent induces sequential conversion of a first population of wound macrophages in the wound to M2A macrophages and a second population of wound macrophages to M2C macrophages. The sequential conversion of the wound macrophages promotes tissue remodeling.

VACUUM EXPANDED DRY COMPOSITION AND SYRINGE FOR RETAINING SAME
20170311939 · 2017-11-02 ·

The present disclosure relates to a method for vacuum expansion of a paste prior to freeze-drying said paste to achieve a dry paste composition which reconstitutes efficiently to form a flowable paste upon addition of an aqueous medium. The present disclosure further relates to a syringe for retaining a dry paste composition in a vacuum.

Wound Dressings and Methods of Making the Same

An article and a method of making the article. The article can include a conformable matrix comprising a mixture of collagen, bioactive glass, and an additive selected from cellulose and/or alginate; wherein the article is a conformable wound dressing. Methods of making articles and methods of using articles to treat wounds are described.

Gelatin-transglutaminase hemostatic dressings and sealants
09655988 · 2017-05-23 · ·

An adhesive material for medical use comprising gelatin and a non-toxic cross-linking material such as transglutaminase. An optional embodiment of the invention includes dressings in which a layer of a transglutaminase is sandwiched between a first and second layer of gelatin. The hemostatic products are useful for the treatment of wounded tissue.

Gelatin-transglutaminase hemostatic dressings and sealants
09636433 · 2017-05-02 · ·

An adhesive material for medical use comprising gelatin and a non-toxic cross-linking material such as transglutaminase. An optional embodiment of the invention includes dressings in which a layer of a transglutaminase is sandwiched between a first and second layer of gelatin. The hemostatic products are useful for the treatment of wounded tissue.

ARTIFICIAL DRESSING, USE OF ARTIFICIAL DRESSING FOR PROMOTING WOUND HEALING AND METHOD OF MANUFACTURING ARTIFICIAL DRESSING

An artificial dressing, use of artificial dressing for promoting wound healing and method of manufacturing artificial dressing are disclosed. The artificial dressing comprises a gelatin, a polysorbate 20 and a glutaraldehyde for promoting wound healing. The manufacturing method of the artificial dressing comprises the steps of enabling the composition of the gelatin, the polysorbate 20 and the glutaraldehyde to perform a foaming step, a molding step and a freeing step in sequence. The artificial dressing has obvious pores and is capable of absorbing a liquid weight about 25-35 times of its body weight. After thermal disintegration experiments and adhesion tests, disintegration of the artificial dressing is not observed, and in animal experiments, compared with commercially available dressings, the artificial dressing of the invention is capable of accelerating wound healing when applied dryly; and capable of proliferating functional tissues of the wound when applied wetly.